Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 4, 2012, Pages 673-682

  Opalinska, Marta ^a   Stompor, Tomasz ^b   Pach, Dorota ^a   Mikolajczak, Renata ^a   Fedak, Danuta ^a   Krzanowski, Marcin ^a,c   Rakowski, Tomasz ^a   Sowa Staszczak, Anna ^a   Glowa, Boguslaw ^a   Garnuszek, Piotr ^c   Maurin, Michal ^c   Karczmarczyk, Urszula ^c   Sulowicz, Wladyslaw ^a   Hubalewska Dydejczyk, Alicja ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^c NATIONAL CENTRE FOR NUCLEAR RESEARCH   (Poland)

Author keywords

99mTc IL 2; End stage renal disease (ESRD); Inflammation; Scintigraphy. Vulnerable plaque

Indexed keywords

ADIPONECTIN; ALBUMIN; AMYLOID A PROTEIN; ANGIOTENSIN RECEPTOR ANTAGONIST; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CD40 LIGAND; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HEMOGLOBIN; HOMOCYSTEINE; HYDRAZINONICOTINAMIDE INTERLEUKIN 2 TECHNETIUM TC 99M; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 18; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; T LYMPHOCYTE;

BIOLOGICAL TRANSPORT; CAROTID ARTERIES; FEMALE; HEMOGLOBINS; HUMANS; INFLAMMATION; INTERLEUKIN-12; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PLAQUE, ATHEROSCLEROTIC; RISK;

EID: 84862534576     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-2026-3     Document Type: Article

References (28)

1. Malek TR. The main function of IL-2 is to promote the development of T regulatory cells. J Leukoc Biol 2003; 74:961-5.
2. Hoyer KK, Dooms H, Barron L, Abbas AK. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 2008; 226:19-28.
3. 99mTc-interleukin-2 and (99m)Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease. Eur J Nucl Med Mol Imaging 2003; 30:374-82.
4. Signore A, Chianelli M, Annovazzi A, Rossi M, Maiuri L, Greco M, et al. Imaging active lymphocytic infiltration in coeliac disease with iodine-123-interleukin-2 and the response to diet. Eur J Nucl Med 2000; 27:18-24.
5. Chianelli M, Mather SJ, Grossman A, Sobnak R, Fritzberg A, Britton KE, et al. (99m)Tc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study. Eur J Nucl Med Mol Imaging 2008; 35:2286-93.
6. 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. Eur J Nucl Med Mol Imaging 2006; 33:117-26.
7. Hubalewska-Dydejczyk A, Stompór T, Kalembkiewicz M, Krzanowski M, Mikolajczak R, Sowa-Staszczak A, et al. Identification of the inflamed atherosclerotic plaque using 123I-labeled interleukin-2 scintigraphy in high-risk peritoneal dialysis patients: a pilot study. Perit Dial Int 2009; 29:568-74.
8. Tonbul HZ, Demir M, Altintepe L, Güney I, Yeter E, Türk S, et al. Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients. Ren Fail 2006; 28:287-94.
9. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Fermo I, Focà A, et al. Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J Hypertens 2000; 18:1207-13.
10. Zoccali C, Benedetto FA, Maas R, Mallamaci F, Tripepi G,Malatino LS, et al. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol 2002; 13:490-6.
11. Armstrong EJ, Morrow DA, SabatineMS. Inflammatory biomarkers in acute coronary syndromes: part I: introduction and cytokines. Circulation 2006; 113(6):e72-5.
12. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes: part II: acute-phase reactants and biomarkers of endothelial cell activation. Circulation 2006; 113(7): e152-5.
13. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes: part III: biomarkers of oxidative stress and angiogenic growth factors. Circulation 2006; 113(8):e289-92.
14. Armstrong EJ, Morrow DA, Sabatine MS. Inflammatory biomarkers in acute coronary syndromes: part IV: matrix metalloproteinases and biomarkers of platelet activation. Circulation 2006; 113(9):e382-5.
15. 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide. Nucl Med Biol 2010; 37(7):795-803.
16. Tsimikas S. Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies. Am J Cardiol 2002; 90(10C):22L-7L.
17. Mettinger KL, Larsson S, Ericson K, Casseborn S. Detection of atherosclerotic plaques in carotid arteries by the use of 123Ifibrinogen. Lancet 1978; 1(8058):242-4.
18. 99mTc-labeled low density lipoproteins. Arteriosclerosis 1988; 8:461-70.
19. Iuliano L, Signore A, Vallabajosula S, Colavita AR, Camastra C, Ronga G, et al. Preparation and biodistribution of 99m technetium labelled oxidized LDL in man. Atherosclerosis 1996; 126 (1):131-41.
20. Demacker PN,Dormans TP,Koenders EB, Corstens FH. Evaluation of indium-111-polyclonal immunoglobulin G to quantitate atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy: effect of age and treatment with antioxidants or ethinylestradiol. J Nucl Med 1993; 34:1316-21.
21. Moriwaki H, Matsumoto M, Handa N, Isaka Y, Hashikawa K, Oku N, et al. Functional and anatomic evaluation of carotid atherothrombosis. A combined study of indium 111 platelet scintigraphy and B-mode ultrasonography. Arterioscler Thromb Vasc Biol 1995; 15:2234-40.
22. Minar E, Ehringer H, Dudczak R, Schöfl R, Jung M, Koppensteiner R, et al. Indium-111-labeled platelet scintigraphy in carotid atherosclerosis. Stroke 1989; 20:27-33.
23. Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation 2001; 104(2):203-8.
24. Carrió I, Pieri PL, Narula J, Prat L, Riva P, Pedrini L, et al. Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells. J Nucl Cardiol 1998; 5(6):551-7.
25. Font MA, Fernandez A, Carvajal A, Gamez C, Badimon L, Slevin M, et al. Imaging of early inflammation in low-to-moderate carotid stenosis by 18-FDG-PET. Front Biosci 2009; 14:3352-60.
26. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18F]- fluorodeoxyglucose positron emission tomography. Circulation 2002; 105(23):2708-11.
27. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factoralpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000; 102:2636-42.
28. Kaden JJ, Dempfle CE, Grobholz R, Fischer CS, Vocke DC, Kiliç R, et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol 2005; 14:80-7.